Trademark Overview
On Wednesday, March 4, 2026, a trademark application was filed for DOMNEXVI with the United States Patent and Trademark Office. The USPTO has given the DOMNEXVI trademark a serial number of 99682808. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 4, 2026. This trademark is owned by Gilead Sciences Ireland UC. The DOMNEXVI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of HIV infection; Pharmaceutical preparations for the treatment of viral infection, fungal infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, oncological diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders, endocrine diseases and disorders, and gastrointestinal diseases and disorders